Over $15m invested in AK University biotech startup
TamoRx aims to develop world-leading cancer immunotherapy.
Dr Joanna Mathy along with Professor Rod Dunbar are behind the novel discovery.
Fiona Rotherham
Wed, 25 May 2022
Biotech startup TamoRx has received $15.25 million in investment to speed up development of a new cancer treatment.
The startup, spun out recently from the University of Auckland, was founded by Dr Joanna Mathy and Professor Rod Dunbar from the university’s school of Biological Sciences.
It is
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
NZ Aviation News
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Aviation News - Monthly
NZ$14.95 / monthly
Already have an account? Login
Fiona Rotherham
Wed, 25 May 2022
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Over $15m invested in AK University biotech startup
Business,
94177